Axsome Therapeutics, Inc. (AXSM): Net Income
-$183.17M
Year ended 2025-12-31
-$191.64M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$183.17M | n/m | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | -$287.22M | n/m | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | -$239.24M | n/m | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | -$187.13M | n/m | 2025-02-18, From 2022-01-01 |
| 2021-12-31 | -$130.40M | n/m | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | -$102.90M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$68.35M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$30.97M | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$28.94M | n/m | 2020-03-12, From 2017-01-01 |
| 2016-12-31 | -$27.20M | n/m | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | -$12.21M | n/m | 2018-03-07, From 2015-01-01 |
| 2014-12-31 | -$6.00M | n/a | 2017-03-07, From 2014-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | -$183.17M | n/m |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $447.18M | n/m |
| Opko Health, Inc. (OPK) | 2025-12-31 | -$225.68M | n/m |
| Insmed Inc (INSM) | 2025-12-31 | -$1.28B | n/m |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | -$575.00M | n/m |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $59.01M | n/m |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | -$38.55M | n/m |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $98.09M | -38.5% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $37.03M | n/m |
Compare AXSM, TGTX, OPK, INSM side by side · Screen every company in Pharmaceutical Preparations ↗